资讯
Private label isn’t playing backup anymore, it’s running the show. Once the bottom-shelf generic you bought with a sigh, ...
Some observers see risks to becoming over-reliant on local facilities, noting the potential need for trade partners if ...
Travoprost is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ...
Small fashion entrepreneurs struggle with manufacturers demanding thousands of pieces upfront, but seven companies offer ...
Shares of Zydus Lifesciences are likely in focus after its subsidiary, ZyVet Animal Health, launched the first FDA-approved generic treatment for canine urinary incontinence in the U.S. The ...
Indian markets could be overestimating US Fed rate cut impact, equity tag for REITs a step towards global best practices, ...
Viatris Inc. (NASDAQ:VTRS)’s strategic emphasis on complex generics and specialty products highlights its shift from a ...
WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial ...
The Massachusetts Department of Public Health said that morphine medication continues to experience intermittent stock issues ...
Zacks Investment Research on MSN
Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?
AbbVie ABBV has gained 22.5% so far this year against a decrease of 0.1% for the industry. The stock has also outperformed ...
Haut.AI, the award-winning leader in AI-powered skin analysis and personalisation, today announced the launch of Skin.Chat, ...
Elastic N.V.'s GenAI adoption accelerates, with over 2,200 customers and strong upmarket enterprise traction. Click here to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果